PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn

Cochrane review into antidepressants used for pain found that the most commonly-recommended drugs lack sufficient evidence of their effectiveness

Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn
2023-05-10
(Press-News.org) Largest ever investigation into antidepressants used for chronic pain shows insufficient evidence to determine how effective or harmful they may be Study reviewed commonly prescribed medications including amitriptyline, duloxetine, fluoxetine, citalopram, paroxetine, and sertraline One third of people globally are living with long-term pain with many prescribed antidepressants to relieve symptoms  

Most antidepressants used for chronic pain are being prescribed with “insufficient” evidence of their effectiveness, scientists have warned.

A major investigation into medications used to manage long-term pain found that harms of many of the commonly recommended drugs have not been well studied.

The Cochrane review, led by scientists from several UK universities including Southampton and Newcastle, examined 176 trials consisting of nearly 30,000 patients involved in assessments which prescribed antidepressants for chronic pain.

Among the drugs studied were amitriptyline, fluoxetine, citalopram, paroxetine, sertraline, and duloxetine – with only the latter showing reliable evidence for pain relief. One third of people globally are living with chronic pain, World Health Organisation data shows, with many prescribed antidepressants for relieving symptoms.

Lead author Professor Tamar Pincus from the University of Southampton said: “This is a global public health concern. Chronic pain is a problem for millions who are prescribed antidepressants without sufficient scientific proof they help, nor an understanding of the long-term impact on health.

“Our review found no reliable evidence for the long-term efficacy of any antidepressant, and no reliable evidence for their safety for chronic pain at any point. Though we did find that duloxetine provided short-term pain relief for patients we studied, we remain concerned about its possible long-term harm due to the gaps in current evidence.”

Amitriptyline is one of the most commonly prescribed antidepressants for pain management worldwide. In the last 12 months, around ten million prescriptions were given to patients in England at the 10mg dose recommended for pain. By comparison, five million prescriptions were given at the higher doses recommended for depression.

For duloxetine, three and a half million prescriptions were dispensed in England, but the recommended doses do not currently differ between conditions.

The two-year Cochrane study was the largest ever assessment of antidepressants recommended by leading bodies including the UK’s National Institute for Health and Care Excellence (NICE) and the Food and Drug Administration (FDA) in the USA.

Statistician Gavin Stewart, review co-author from Newcastle University, said: “We are calling on governing health bodies NICE and the FDA to update their guidelines to reflect the new scientific evidence, and on funders to stop supporting small and flawed trials. Evidence synthesis is often complex and nuanced but the evidence underpinning the use of these treatments is not equivalent, so current treatment modalities are hard to justify.”

The review revealed that duloxetine was consistently the highest-rated medication and was equally as effective for fibromyalgia, musculoskeletal, and neuropathic pain conditions.

Other results showed:

Standard doses of duloxetine are as successful for reducing pain as higher quantities, Milnacipran was also effective at reducing pain, but scientists are not as confident as duloxetine due to fewer studies with fewer people. Prof Tamar Pincus added: “We simply cannot tell about other antidepressants because sufficiently good studies are not available – but it does not mean that people should stop taking prescribed medication without consulting their GP.”

Scientists responsible for the review, funded by the NIHR’s Health Technology Assessment programme, were from the universities of Southampton, Newcastle, Bristol, UCL, Bath, and Keele, alongside Oxford University Hospital.

The team assessed the trials using a statistical method that enables researchers to combine data from relevant studies to estimate the effects of different drugs, which have not been compared directly in individual trials.

University of Southampton researcher Dr Hollie Birkinshaw said: “Though previous investigations show that some antidepressants might relieve pain, there has never been a comprehensive study examining all medications across all chronic conditions – until now.

“The only reliable evidence is for duloxetine. Adopting a person-centred approach is critical to treatment, and when patients and clinicians decide together to try antidepressants they should start from the drug for which there is good evidence.”

The Cochrane review can be read at http://dx.doi.org/10.1002/14651858.CD014682.pub2.

ENDS

627 WORDS

END

[Attachments] See images for this press release:
Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn 2 Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn 3

ELSE PRESS RELEASES FROM THIS DATE:

Dark clouds on the horizon

Dark clouds on the horizon
2023-05-10
Our industrialized society releases many and various pollutants into the world. Combustion in particular produces aerosol mass including black carbon. Although this only accounts for a few percent of aerosol particles, black carbon is especially problematic due to its ability to absorb heat and impede the heat reflection capabilities of surfaces such as snow. So, it’s essential to know how black carbon interacts with sunlight. Researchers have quantified the refractive index of black carbon to the most accurate degree yet which might impact climate models. There are many factors driving climate change; some are very familiar, such ...

Scientists discover microbes in the Alps and Arctic that can digest plastic at low temperatures

2023-05-10
Finding, cultivating, and bioengineering organisms that can digest plastic not only aids in the removal of pollution, but is now also big business. Several microorganisms that can do this have already been found, but when their enzymes that make this possible are applied at an industrial scale, they typically only work at temperatures above 30°C. The heating required means that industrial applications remain costly to date, and aren’t carbon-neutral. But there is a possible solution to this problem: ...

Salt marshes protect the coast – but not where it is needed most

Salt marshes protect the coast – but not where it is needed most
2023-05-10
Salt marshes provide multiple ecosystem services, one of those is protection of the coast against flooding. This is especially important in low-lying countries like the Netherlands. Scientists from the University of Groningen and the Royal Netherlands Institute for Sea Research (NIOZ), in collaboration with the local water authority, have monitored wave run-up during storms over a three-year period. The results, which were published in the Journal of Applied Ecology on 10 May, help the water authority to quantify the protective effect of salt marshes. For three years, ecologist Beatriz Marin-Diaz always had one eye on the weather ...

New USC study shows immigrant adults with liver cancer have higher survival rates than those born in the US

2023-05-10
Immigrant adults with liver cancer in the United States have higher survival rates than people with the disease who were born in the U.S., according to new research from the USC Norris Comprehensive Cancer Center. Hepatocellular carcinoma (HCC), the most common form of liver cancer, contributes to more than 27,000 deaths annually in the United States. Immigrants comprise a significant proportion of those diagnosed with HCC in the U.S. Research has shown that birthplace, also referred to as nativity, impacts incidence and risk factors for HCC, but little was known about its influence on survival after diagnosis. The new study, just published in the Journal of the National ...

Physicists discover ‘stacked pancakes of liquid magnetism’

Physicists discover ‘stacked pancakes of liquid magnetism’
2023-05-10
HOUSTON – (May 10, 2023) – Physicists have discovered “stacked pancakes of liquid magnetism” that may account for the strange electronic behavior of some layered helical magnets. The materials in the study are magnetic at cold temperatures and become nonmagnetic as they thaw. Experimental physicist Makariy Tanatar of Ames National Laboratory at Iowa State University noticed perplexing electronic behavior in layered helimagnetic crystals and brought the mystery to the attention of Rice theoretical physicist Andriy Nevidomskyy, who worked with Tanatar and former Rice graduate student Matthew Butcher to create a computational model that simulated the quantum states ...

Workplace accidents are most likely to occur in moderately dangerous settings

2023-05-10
Although some people might expect very dangerous jobs to be associated with the highest incidence of workplace accidents, a new study finds that accidents are actually most likely to occur within moderately dangerous work environments. “In highly dangerous environments, individuals engage in a high degree of safety behaviours, which offsets the chance of an accident,” said Dr. James Beck, lead author and a professor of psychology. “On the other hand, in moderately dangerous environments, people usually engage in some safety behaviours, yet most people do not engage in enough​ safety ...

Training machines to learn more like humans do

2023-05-09
Imagine sitting on a park bench, watching someone stroll by. While the scene may constantly change as the person walks, the human brain can transform that dynamic visual information into a more stable representation over time. This ability, known as perceptual straightening, helps us predict the walking person’s trajectory. Unlike humans, computer vision models don’t typically exhibit perceptual straightness, so they learn to represent visual information in a highly unpredictable way. But if machine-learning models had this ability, it might enable them to better estimate how objects or people will move. MIT researchers have discovered that a specific training ...

New UCF-developed immunotherapy treatment targets respiratory viral infections

2023-05-09
ORLANDO, May 9, 2023 – A University of Central Florida College of Medicine researcher has developed a new, more precise treatment for a major cause of illness around the world each year — acute respiratory viral infections. Acute respiratory viral infections include sicknesses such as the flu, pneumonia, respiratory syncytial virus (RSV) and coronavirus. These infections cause millions of illnesses worldwide, with the flu alone responsible for 3 million to 5 million cases of severe illness and up to 650,000 respiratory deaths each year, ...

McMaster researchers find best treatment for excessive daytime sleepiness

2023-05-09
Hamilton, ON (March 9, 2023) – McMaster University researchers Dena Zeraatkar and Tyler Pitre have found that the drug solriamfetol is the most effective treatment for excessive daytime sleepiness (EDS) for people with obstructive sleep apnea (OSA).   The standard treatment for OSA is a positive airway pressure (PAP) mask that uses compressed air to support lung airways during sleep. However, some people with OSA still experience EDS and may benefit from anti-fatigue medication.   Zeraatkar ...

Study discovers long COVID risk and symptoms vary in different populations

2023-05-09
The study, published April 7 in Nature Communications, analyzed electronic health records as part of the National Institutes of Health’s Researching COVID to Enhance Recovery (RECOVER) Initiative to better understand the persistence of symptoms after SARS-CoV-2 infection, also known as long COVID, among broad, diverse populations. Led by Dr. Rainu Kaushal, chair of the Department of Population Health Sciences at Weill Cornell Medicine and physician-in-chief of population health sciences at New York-Presbyterian ...

LAST 30 PRESS RELEASES:

ACS Annual Report: Cancer mortality continues to drop despite rising incidence in women; rates of new diagnoses under 65 higher in women than men

Fewer skin ulcers in Werner syndrome patients treated with pioglitazone

Study finds surprising way that genetic mutation causes Huntington’s disease, transforming understanding of the disorder

DNA motors found to switch gears

Human ancestor thrived longer in harsher conditions than previous estimates

Evolution: Early humans adapted to extreme desert conditions over one million years ago

Race and ethnicity and diffusion of telemedicine in Medicaid for schizophrenia care after onset of the COVID-19 pandemic

Changes in support for advance provision and over-the-counter access to medication abortion

Protein level predicts immunotherapy response in bowel cancer

The staying power of bifocal contact lens benefits in young kids

Dose-dependent relationship between alcohol consumption and the risks of hepatitis b virus-associated cirrhosis and hepatocellular carcinoma: A meta-analysis and systematic review

International Alliance for Primary Immunodeficiency Societies selects Rockefeller University Press to publish new Journal of Human Immunity

Leader in mission-driven open publishing wins APE Award for Innovation in Scholarly Communication

Innovative 6D pose dataset sets new standard for robotic grasping performance

Evaluation of plasma neurodegenerative biomarkers for diagnosing minimal hepatic encephalopathy and predicting overt hepatic encephalopathy in Chinese patients with hepatic cirrhosis

MEXICO: How animals, people, and rituals created Teotihuacán

The role of political partisanship and moral beliefs in leadership selection

Parental favoritism isn't a myth

Arctic hotspots study reveals areas of climate stress in Northern Alaska, Siberia

Mount Sinai study finds wearable devices can detect and predict inflammatory bowel disease flare-ups

Peripheral blood CD4+/CD8+ t cell ratio predicts HBsAg clearance in inactive HBsAg carriers treated with peginterferon alpha

MIT Press’s Direct to Open reaches annual funding goal for 2025, opens access to 80 new monographs

New NCCN patient resource shares latest understanding of genetic testing to guide patient decision making

Synchronization in neural nets: Mathematical insight into neuron readout drives significant improvements in prediction accuracy

TLE6 identified as a protein associated with infertility in male mice

Thin lenses have a bright future

Volcanic eruption caused Neolithic people to sacrifice unique "sun stones"

Drug in clinical trials for breast cancer could also treat some blood cancers

Study identifies mechanism underlying increased osteoarthritis risk in postmenopausal females

The material revolution: How USA’s commodity appetite evolved from 1900 to present

[Press-News.org] Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn
Cochrane review into antidepressants used for pain found that the most commonly-recommended drugs lack sufficient evidence of their effectiveness